Primary splenic lymphoma: a case report.

Indian J Surg Oncol

Department of General Surgery, Bangalore Medical College and Research Institute, Bangalore, India.

Published: September 2013

Primary splenic lymphomas (PSL) constitute a rare variety of splenic neoplasms. As a secondary lymphoid organ, the spleen is usually involved by lymphomas as part of the systemic illness. However, rarely it can be the exclusive site of disease burden. An elderly lady presented with symptoms and signs of splenomegaly. After evaluation she was found to have a splenic tumor. Splenectomy was done which revealed primary splenic lymphoma. This case report highlights the evaluation and management of this illness.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771062PMC
http://dx.doi.org/10.1007/s13193-013-0243-xDOI Listing

Publication Analysis

Top Keywords

primary splenic
12
splenic lymphoma
8
lymphoma case
8
case report
8
report primary
4
splenic
4
splenic lymphomas
4
lymphomas psl
4
psl constitute
4
constitute rare
4

Similar Publications

Identifying inflammation-induced leukocyte subsets and their derived circulating factors has been instrumental in understanding the progession of ALI/ARDS. Nevertheless, how primary inflammation-induced non-leukocyte populations in distal organs contribute to ALI/ARDS remains poorly defined. Here, we report one population of erythroblast-like cells (Ter-cells) deriving from megakaryocyte- erythroid progenitor cells with a unique Ter-119+CD45-CD71+ phenotype in ALI/ARDS.

View Article and Find Full Text PDF

Introduction: Observational studies have found that higher iron levels are associated with an increased risk of diabetes mellitus. Given the limitations of causal inferences from observational studies and the expensive and time-consuming nature of randomized controlled trials, Mendelian randomization analysis presents a reasonable alternative to study causal relationships. Previous MR analyses studying iron levels and diabetes have used indirect markers of iron levels, such as serum ferritin, and found conflicting results.

View Article and Find Full Text PDF

Dendritic cells (DCs), the primary antigen-presenting cells, have traditionally been identified by CD103 molecules in rats, whereas mouse and human DCs are identified by CD11c molecules. However, this history does not preclude the existence of CD103 DCs in rats. To explore this possibility, we examined MHCII cells in rat spleen and thymus, identifying a novel population of CD103MHCIICD45RCD172a cells.

View Article and Find Full Text PDF

Early neutrophil activation and NETs release in the pristane-induced lupus mice model.

PLoS One

January 2025

Laboratório de Imunologia Celular (LIM-17), Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Article Synopsis
  • The study investigates the role of NETosis in the initiation of lupus using a mouse model.
  • Mice injected with pristane showed significantly more activated neutrophils and low-density granulocytes, as well as increased release of neutrophil extracellular traps compared to the control group.
  • These findings suggest that early activation of neutrophils and NETosis may contribute to the development of lupus in this model.
View Article and Find Full Text PDF

Evaluating two live-attenuated vaccines against serovar Reading in turkeys: reduced tissue colonization and cecal tonsil transcriptome responses.

Front Vet Sci

December 2024

Food Safety and Enteric Pathogens Research Unit, National Animal Disease Center, U.S. Department of Agriculture-Agricultural Research Service (USDA-ARS), Ames, IA, United States.

Vaccines that cross-protect across serovars of () would be a beneficial intervention against emerging and persistent isolates of concern for the turkey industry. The 2017-2019 foodborne outbreak of serovar Reading (. Reading) revealed the need for effective control of this serovar in turkey production.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!